News News December, 2020 IGM Biosciences Presents First Clinical Data from IGM-2323 in Non-Hodgkin’s Lymphoma at 2020 ASH Annual Meeting Read More... November, 2020 IGM Biosciences to Host Conference Call and Webcast to Review IGM-2323 Data Presented at the 62nd Annual ASH Meeting Read More... November, 2020 IGM Biosciences to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More... November, 2020 IGM Biosciences to Present at Three Upcoming Investor Conferences Read More... November, 2020 IGM Biosciences Announces Third Quarter 2020 Financial Results and Provides Corporate Update Read More... November, 2020 IGM Biosciences to Present First Clinical Data from IGM-2323 in Non-Hodgkin’s Lymphoma at 2020 ASH Annual Meeting Read More... September, 2020 IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-8444 for the Treatment of Solid Cancers and Non-Hodgkin’s Lymphoma Read More... September, 2020 AbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery Collaboration Read More... September, 2020 IGM Biosciences to Present at Four Upcoming Investor Conferences Read More... August, 2020 IGM Biosciences Announces Second Quarter 2020 Financial Results and Provides Corporate Update Read More... « Previous 1 2 3 4 5 Next »
